BIIL 260   Click here for help

GtoPdb Ligand ID: 6154

Synonyms: BIIL-260 | BIIL260
PDB Ligand
Compound class: Synthetic organic
Comment: BIIL 260 is a leukotriene B4 (BLT1) receptor antagonist and is the active metabolite of the prodrug BIIL 284 (amelubant).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 3
Rotatable bonds 9
Topological polar surface area 88.56
Molecular weight 466.23
XLogP 7.79
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES Oc1ccc(cc1)C(c1ccc(cc1)OCc1cccc(c1)COc1ccc(cc1)C(=N)N)(C)C
Isomeric SMILES Oc1ccc(cc1)C(c1ccc(cc1)OCc1cccc(c1)COc1ccc(cc1)C(=N)N)(C)C
InChI InChI=1S/C30H30N2O3/c1-30(2,24-8-12-26(33)13-9-24)25-10-16-28(17-11-25)35-20-22-5-3-4-21(18-22)19-34-27-14-6-23(7-15-27)29(31)32/h3-18,33H,19-20H2,1-2H3,(H3,31,32)
1. Birke FW, Meade CJ, Anderskewitz R, Speck GA, Jennewein HM. (2001)
In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.
J Pharmacol Exp Ther, 297 (1): 458-66. [PMID:11259574]
2. Díaz-González F, Alten RH, Bensen WG, Brown JP, Sibley JT, Dougados M, Bombardieri S, Durez P, Ortiz P, de-Miquel G et al.. (2007)
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis.
Ann Rheum Dis, 66 (5): 628-32. [PMID:17170051]